Business Description
Zhuhai Rundu Pharmaceutical Co Ltd
ISIN : CNE1000033G8
Share Class Description:
SZSE:002923: Class ACompare
Compare
Traded in other countries / regions
002923.China IPO Date
2018-01-05Description
Zhuhai Rundu Pharmaceutical Co Ltd is engaged in the production and sales of chemical drugs, chemical raw materials, and pharmaceutical intermediates. Its products offerings include APIs medicine, Pellets, intermediate and formulations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.37 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.44 | |||||
| Debt-to-EBITDA | 8.02 | |||||
| Interest Coverage | 6.94 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.32 | |||||
| Beneish M-Score | -3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | 2.3 | |||||
| 3-Year EPS without NRI Growth Rate | -27.5 | |||||
| 3-Year FCF Growth Rate | 31.9 | |||||
| 3-Year Book Growth Rate | 4.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.05 | |||||
| 9-Day RSI | 61.63 | |||||
| 14-Day RSI | 61.24 | |||||
| 3-1 Month Momentum % | 25.87 | |||||
| 6-1 Month Momentum % | 2.52 | |||||
| 12-1 Month Momentum % | -22.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.43 | |||||
| Days Inventory | 250.12 | |||||
| Days Sales Outstanding | 38.22 | |||||
| Days Payable | 92.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.86 | |||||
| Dividend Payout Ratio | 0.95 | |||||
| 3-Year Dividend Growth Rate | 16.7 | |||||
| Forward Dividend Yield % | 1.86 | |||||
| 5-Year Yield-on-Cost % | 2.92 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 1.63 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.29 | |||||
| Operating Margin % | 8.99 | |||||
| Net Margin % | 3.15 | |||||
| FCF Margin % | 9.35 | |||||
| ROE % | 3.28 | |||||
| ROA % | 1.75 | |||||
| ROIC % | 5.15 | |||||
| 3-Year ROIIC % | -4.58 | |||||
| ROC (Joel Greenblatt) % | 4.23 | |||||
| ROCE % | 3.59 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 97.64 | |||||
| PE Ratio without NRI | 50.9 | |||||
| Shiller PE Ratio | 29.83 | |||||
| PEG Ratio | 5.92 | |||||
| PS Ratio | 2.97 | |||||
| PB Ratio | 3.13 | |||||
| Price-to-Tangible-Book | 3.31 | |||||
| Price-to-Free-Cash-Flow | 31.72 | |||||
| Price-to-Operating-Cash-Flow | 15.54 | |||||
| EV-to-EBIT | 62.32 | |||||
| EV-to-EBITDA | 62.32 | |||||
| EV-to-Revenue | 3.24 | |||||
| EV-to-FCF | 33.93 | |||||
| Price-to-GF-Value | 0.93 | |||||
| Price-to-Projected-FCF | 6.36 | |||||
| Price-to-DCF (Earnings Based) | 4.4 | |||||
| Price-to-DCF (FCF Based) | 1.03 | |||||
| Price-to-Graham-Number | 2.74 | |||||
| Earnings Yield (Greenblatt) % | 1.6 | |||||
| FCF Yield % | 3.18 | |||||
| Forward Rate of Return (Yacktman) % | -9.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhuhai Rundu Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,223.509 | ||
| EPS (TTM) (Â¥) | 0.11 | ||
| Beta | 0.86 | ||
| 3-Year Sharpe Ratio | -0.46 | ||
| 3-Year Sortino Ratio | -0.58 | ||
| Volatility % | 38.6 | ||
| 14-Day RSI | 61.24 | ||
| 14-Day ATR (Â¥) | 0.298016 | ||
| 20-Day SMA (Â¥) | 10.342 | ||
| 12-1 Month Momentum % | -22.9 | ||
| 52-Week Range (Â¥) | 6.81 - 13.67 | ||
| Shares Outstanding (Mil) | 334.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhuhai Rundu Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhuhai Rundu Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhuhai Rundu Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923)'s stock price today?
The current price of SZSE:002923 is ¥10.74. The 52 week high of SZSE:002923 is ¥13.67 and 52 week low is ¥6.81.
When is next earnings date of Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923)?
The next earnings date of Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923) is .
Does Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923) pay dividends? If so, how much?
The Dividend Yield %  of Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923) is 1.86% (As of Today), Highest Dividend Payout Ratio of Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923) was 2.69. The lowest was 0.58. And the median was 0.75. The  Forward Dividend Yield % of Zhuhai Rundu Pharmaceutical Co Ltd(SZSE:002923) is 1.86%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers